{"status":"success","data":{"title":"Pneumonia Risk Stratification Tools","slug":"pneumonia-severity","tags":null,"collection":["Pulmonology","Infectious Disease","EBM"],"content":"<h1 id=\"pneumonia-risk-stratification-scoring-tools\">Pneumonia: Risk Stratification Scoring Tools</h1>\n<h2 id=\"pneumonia-severity-index-psi-\">Pneumonia Severity Index (PSI)</h2>\n<ul>\n<li>From Pneumonia Patient Outcomes Research Team (PORT) </li>\n<li>A large derivation and validation study with &gt; 50,000 patients</li>\n<li>Best identifies low-risk/ low-mortality patients</li>\n<li>Tends to miss higher-risk pneumonia in younger patients because score is based on age </li>\n<li>Does not factor in immunosuppression (eg. HIV) and poor social support. </li>\n</ul>\n<table>\n<thead>\n<tr>\n<th><strong>Risk factors</strong></th>\n<th><strong>Points</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Men</td>\n<td>Age (years)</td>\n</tr>\n<tr>\n<td>Women</td>\n<td>Age (years)-10</td>\n</tr>\n<tr>\n<td>Nursing home resident</td>\n<td>+10</td>\n</tr>\n<tr>\n<td>History of neoplasm</td>\n<td>+30</td>\n</tr>\n<tr>\n<td>History of liver disease</td>\n<td>+20</td>\n</tr>\n<tr>\n<td>History of heart failure</td>\n<td>+10</td>\n</tr>\n<tr>\n<td>History of stroke</td>\n<td>+10</td>\n</tr>\n<tr>\n<td>History of renal failure</td>\n<td>+10</td>\n</tr>\n<tr>\n<td>Altered mental status</td>\n<td>+20</td>\n</tr>\n<tr>\n<td>RR ≥ 30 breaths/ min</td>\n<td>+20</td>\n</tr>\n<tr>\n<td>SBP &lt; 90 mmHg</td>\n<td>+20</td>\n</tr>\n<tr>\n<td>Temp &lt; 95F (35C) or ≥104F (40C)</td>\n<td>+15</td>\n</tr>\n<tr>\n<td>HR ≥ 125 bpm</td>\n<td>+10</td>\n</tr>\n<tr>\n<td>Arterial pH &lt; 7.35</td>\n<td>+30</td>\n</tr>\n<tr>\n<td>BUN &gt; 30 mg/dL</td>\n<td>+20</td>\n</tr>\n<tr>\n<td>Na &lt; 130 mmol/L</td>\n<td>+20</td>\n</tr>\n<tr>\n<td>Glucose ≥250 mg/dL</td>\n<td>+10</td>\n</tr>\n<tr>\n<td>Hematocrit &lt; 30%</td>\n<td>+10</td>\n</tr>\n<tr>\n<td>PaO2 &lt; 60 mmHg</td>\n<td>+10</td>\n</tr>\n<tr>\n<td>Pleural effusion</td>\n<td>+10</td>\n</tr>\n</tbody>\n</table>\n<table>\n<thead>\n<tr>\n<th><strong>PSI Class</strong></th>\n<th><strong>Total points</strong></th>\n<th><strong>30-day mortality</strong></th>\n<th><strong>Disposition</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>I</td>\n<td>&lt; 51</td>\n<td>0.1%</td>\n<td>Outpatient</td>\n</tr>\n<tr>\n<td>II</td>\n<td>51-70</td>\n<td>0.6%</td>\n<td>Outpatient</td>\n</tr>\n<tr>\n<td>III</td>\n<td>71-90</td>\n<td>0.9%</td>\n<td>Outpatient vs short-stay inpatient</td>\n</tr>\n<tr>\n<td>IV</td>\n<td>91-130</td>\n<td>9.3%</td>\n<td>Inpatient</td>\n</tr>\n<tr>\n<td>V</td>\n<td>&gt; 130</td>\n<td>27.0%</td>\n<td>Inpatient ICU</td>\n</tr>\n</tbody>\n</table>\n<p>(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086\">Fine et al., JAMA 1997)</a></p>\n<h2 id=\"curb-65-severity-score\">CURB-65 Severity Score</h2>\n<p>* Supported by British Thoracic Society (BTS)</p>\n<ul>\n<li>Best identifies high-risk/ high-mortality patients</li>\n<li>Tends to misclassify moderate-risk pneumonia patients (as low-risk) </li>\n<li>Does not account for co-morbidities and hypoxemia</li>\n</ul>\n<table>\n<thead>\n<tr>\n<th></th>\n<th><strong>Risk factor</strong></th>\n<th><strong>Points</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td><strong>C</strong></td>\n<td><strong>C</strong>onfusion</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>U</strong></td>\n<td>Uremia (BUN &gt;19 mg/dL)</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>R</strong></td>\n<td><strong>R</strong>R ≥ 30 breaths/min</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>B</strong></td>\n<td><strong>B</strong>P low (SBP &lt; 90 mmHg or DBP &lt; 60 mmHg)</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>65</strong></td>\n<td>Age ≥ <strong>65</strong> years</td>\n<td>1</td>\n</tr>\n</tbody>\n</table>\n<table>\n<thead>\n<tr>\n<th><strong>Total points</strong></th>\n<th><strong>30-day mortality</strong></th>\n<th><strong>Disposition</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>0</td>\n<td>0.6%</td>\n<td>Outpatient</td>\n</tr>\n<tr>\n<td>1</td>\n<td>3.2%</td>\n<td>Outpatient</td>\n</tr>\n<tr>\n<td>2</td>\n<td>13.0%</td>\n<td>Outpatient or short-stay inpatient</td>\n</tr>\n<tr>\n<td>3</td>\n<td>17%</td>\n<td>Inpatient</td>\n</tr>\n<tr>\n<td>4</td>\n<td>41.5%</td>\n<td>Inpatient, likely ICU</td>\n</tr>\n<tr>\n<td>5</td>\n<td>57.0%</td>\n<td>Inpatient ICU</td>\n</tr>\n</tbody>\n</table>\n<p>(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364\">British Thoracic Society Standards of Care Committee</a> &amp;<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136\"> </a><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136\">Aujesky et al, Am J Med, 2005</a>) </p>\n<h2 id=\"smart-cop\">SMART-COP</h2>\n<p>Supported by Australian CAP Study</p>\n<ul>\n<li>Tool to predict need for intensive respiratory or vasopressor support (IRVS) </li>\n</ul>\n<table>\n<colgroup>\n<col width=\"33%\" />\n<col width=\"33%\" />\n<col width=\"33%\" />\n</colgroup>\n<thead>\n<tr class=\"header\">\n<th><br />\n</th>\n<th><strong>Risk factor</strong></th>\n<th><strong>Points</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr class=\"odd\">\n<td><strong>S</strong></td>\n<td><strong>S</strong>ystolic BP &lt; 90 mmHg</td>\n<td>2</td>\n</tr>\n<tr class=\"even\">\n<td><strong>M</strong></td>\n<td><strong>M</strong>ultilobar CXR involvement</td>\n<td>1</td>\n</tr>\n<tr class=\"odd\">\n<td><strong>A</strong></td>\n<td><strong>A</strong>lbumin &lt; 3.5 g/dL</td>\n<td>1</td>\n</tr>\n<tr class=\"even\">\n<td><strong>R</strong></td>\n<td>If age ≤ 50 years: <strong>R</strong>R ≥ 25 breaths/min <br />\nIf age &gt; 50 years: <strong>R</strong>R ≥ 30 breaths min <br />\n</td>\n<td>1</td>\n</tr>\n<tr class=\"odd\">\n<td><strong>T</strong></td>\n<td><strong>T</strong>achycardia HR ≥ 125 bpm </td>\n<td>1</td>\n</tr>\n<tr class=\"even\">\n<td><strong>C</strong></td>\n<td><strong>C</strong>onfusion (new onset)</td>\n<td>1<br />\n</td>\n</tr>\n<tr class=\"odd\">\n<td><strong>O</strong></td>\n<td><strong>O</strong>xygen low<br />\n\n<p>If age ≤50 years: </p>\n<ul>\n<li>PaO2 &lt; 70 mmHg, or<br />\n</li>\n<li>O2 sat ≤ 93%, or<br />\n</li>\n<li>PaO2/FiO2 &lt; 333<br />\n</li>\n</ul>\n<p>If age &gt;50 years:</p>\n<ul>\n<li>PaO2 &lt; 60 mmHg, or</li>\n<li>O2 sat ≤ 90%, or </li>\n<li>PaO2/FiO2 &lt; 250 </li>\n</ul></td>\n<td>2</td>\n</tr>\n<tr class=\"even\">\n<td><strong>P</strong></td>\n<td>Arterial <strong>p</strong>H &lt; 7.35</td>\n<td>2</td>\n</tr>\n</tbody>\n</table>\n\n<table>\n<thead>\n<tr>\n<th><strong>Total points</strong></th>\n<th><strong>Risk of needing IRVS</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>0-2</td>\n<td>Low</td>\n</tr>\n<tr>\n<td>3-4</td>\n<td>Moderate ( 1 in 8)</td>\n</tr>\n<tr>\n<td>5-6</td>\n<td>High (1 in 3)</td>\n</tr>\n<tr>\n<td>≥ &amp;</td>\n<td>Very high (2 in 3)</td>\n</tr>\n</tbody>\n</table>\n<p>(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884\">Charles et al., Clin Infect Dis, 2008</a>)</p>\n<h2 id=\"references\">References</h2>\n<ul>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136\">Aujesky D et. al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005 Apr;118(4):384-92.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086\">Fine MJ et. al. A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med. 1997 Jan 23;336(4):243-50.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884\">Charles PG et. al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008 Aug 1;47(3):375-84.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364\">British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax. 2001 Dec;56 Suppl 4:IV1-64.</a></li>\n</ul>\n"}}